Stroke Trial, Recruiting NCT05845047 Sponsor: Johns Hopkins University Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05845047
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who were proficient in English before their stroke
  • People who have had a stroke on the left side of the brain (either a blocked blood vessel or a bleed), confirmed by a brain scan, where the stroke happened either between 1 and 4 months ago, or 6 or more months ago
  • People who have been diagnosed with aphasia (a communication difficulty) as a result of their stroke, based on a specific language assessment score
  • People who are able to give their own consent to participate, or who have someone else who can give consent on their behalf

Who may not be able to join:

  • People who have a history of a brain condition other than stroke, such as a brain tumour, multiple sclerosis, or a traumatic brain injury
  • People who have a history of a serious psychiatric illness, developmental disorder, or intellectual disability, such as PTSD, schizophrenia, obsessive-compulsive disorder, or autism spectrum disorder
  • People who are unable to engage with the treatment process during initial test probes, even if their responses are not accurate (confirm with trial site)
  • People who have severe vision or hearing loss that has not been corrected, based on what they report and what their medical records show

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Argye E Hillis, MD, Johns Hopkins University

Phone: 410-614-2381

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
31 May 2023
Est. completion
1 August 2031

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in discourse content as assessed by z-score for the number of meaning-carrying units used in describing a picture

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov